{
    "Symbol": "BIO",
    "AssetType": "Common Stock",
    "Name": "Bio-Rad Laboratories Inc",
    "Description": "Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.",
    "CIK": "12208",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
    "Address": "1000 ALFRED NOBEL DRIVE, HERCULES, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "14042743000",
    "EBITDA": "624216000",
    "PERatio": "None",
    "PEGRatio": "1.074",
    "BookValue": "324.89",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "-123.81",
    "RevenuePerShareTTM": "94.08",
    "ProfitMargin": "-1.294",
    "OperatingMarginTTM": "0.174",
    "ReturnOnAssetsTTM": "0.0194",
    "ReturnOnEquityTTM": "-0.311",
    "RevenueTTM": "2802249000",
    "GrossProfitTTM": "1568430000",
    "DilutedEPSTTM": "-123.81",
    "QuarterlyEarningsGrowthYOY": "1.978",
    "QuarterlyRevenueGrowthYOY": "-0.003",
    "AnalystTargetPrice": "616.8",
    "TrailingPE": "-",
    "ForwardPE": "28.01",
    "PriceToSalesRatioTTM": "4.418",
    "PriceToBookRatio": "1.517",
    "EVToRevenue": "4.358",
    "EVToEBITDA": "-1.591",
    "Beta": "0.913",
    "52WeekHigh": "623.37",
    "52WeekLow": "344.63",
    "50DayMovingAverage": "447.53",
    "200DayMovingAverage": "463.12",
    "SharesOutstanding": "24521600",
    "DividendDate": "None",
    "ExDividendDate": "None"
}